🎯 Schemes & WelfareMAINS · GS2.13

World Homoeopathy Day spotlights AYUSH institutions

A backgrounder that maps homoeopathy's statutory regulator, its research body and the AYUSH scheme family ahead of the 10 April observance.

What happened

Background & context

Homoeopathy is one of the five recognised AYUSH systems — Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy — that the Government of India treats as a distinct stream of traditional and complementary medicine. The day exists because the system has a single, datable founder. Samuel Hahnemann (1755–1843) was a German physician who formalised the method in 1796; his foundational text, the Organon of Medicine, still guides practice. The word itself comes from the Greek Homois (similar) and Pathos (suffering) — medicine that treats a disease using a substance that, in a healthy person, would produce symptoms similar to the disease.

The system rests on two stated principles. The first, "like cures like" (similia similibus curentur), holds that a substance causing symptoms in a healthy person can, in minute form, treat similar symptoms in a sick one. The second, the "law of minimum dose", holds that the lower the dose, the greater the claimed therapeutic effect — remedies are highly diluted through serial dilution and succussion (vigorous shaking), and are drawn from natural plant, mineral and animal sources. A defining feature is its individualised approach: the remedy is matched to the whole symptom-picture of the person, not a single named disease.

Homoeopathy reached India early. John Martin Honigberger, a disciple of Hahnemann, began practising around 1810; his treatment of Maharaja Ranjit Singh in 1839 raised the system's standing. One of the earliest homoeopathic hospitals was established at Tanjore (Thanjavur), Tamil Nadu, in 1847, and the system was championed in Bengal by Rajendra Lal Dutta and Mahendra Lal Sircar. After Independence the institutional scaffolding was built in two steps that students must keep distinct: the Central Council of Homoeopathy in 1973 (the education/registration regulator) and the Central Council for Research in Homoeopathy in 1978 (the research body). That 1973 regulator was later dissolved and replaced — the central fact this backgrounder is built around.

For Prelims

For UPSC: The NCH (under the NCH Act, 2020, in force 5 July 2021) is the statutory regulator that replaced the Central Council of Homoeopathy (1973 Act); the CCRH (1978) is the research body; the PCIM&H is the pharmacopoeia/drug-testing office — all three sit under the Ministry of AYUSH (2014).
What it is NOT: The NCH is not the same as the old Central Council of Homoeopathy — the Council was dissolved when the NCH Act took effect. The NCH is also not a research or drug-standardisation body: research is CCRH's job and pharmacopoeia/drug-testing is PCIM&H's. The NCH belongs to the same family of post-2019 commission-style regulators as the National Medical Commission (NMC Act, 2019) and the National Commission for Indian System of Medicine (NCISM Act, 2020) — which regulates Ayurveda, Unani, Siddha and Sowa-Rigpa, not homoeopathy. Do not confuse NCH (homoeopathy) with NCISM (the other Indian systems).

The full AYUSH scheme set

Because "how many of these / match the pairs" questions live in the scheme list, the backgrounder names the homoeopathy-supporting schemes explicitly. Carry the complete set:

Why it matters

The day is a hook, but the examinable substance is the governance architecture of a recognised system of medicine. Homoeopathy in India is large enough — 3.45 lakh registered practitioners and a national network of dispensaries, colleges and research units — that its regulation is a live question of public health governance, professional standards and consumer protection. The shift from the 1973 Council to the 2020 Commission is the same reform logic that produced the National Medical Commission: replacing an elected-council model criticised for capture with a leaner, nominated commission meant to raise academic standards, clean up the register of practitioners and tighten ethics. That is precisely the kind of "government policy and intervention for development in the health sector" the syllabus tests.

The 2026 framing — "Homoeopathy for Sustainable Health" — also ties the system to two larger debates: the integration of traditional medicine into mainstream healthcare (co-location at health centres, the Ayushman Arogya Mandir network) and the quality-and-evidence question that surrounds AYUSH systems. The backgrounder is candid that the work ahead is "strengthening scientific validation, ethical standards, and integration," which is itself an admission that evidence standardisation is the system's open problem — a useful, source-anchored way-forward and problematisation for an answer.

Finally, the schemes attach homoeopathy to India's medicinal-plants economy and biodiversity: with 7,000–7,500 species supported through the NMPB and an explicit "eco-friendly pharmaceutical practices" and "biodiversity conservation" framing, the sector links health policy to conservation and to the traditional-knowledge debate — the same terrain as the Biological Diversity Act and access-and-benefit-sharing.

For Mains

Anchor
A question on regulating professional education and standards in the health sector can be anchored on the NCH (NCH Act, 2020): a commission-style statutory regulator replacing the 1973 Central Council, mirroring the NMC and NCISM reforms.
Data
India's homoeopathy footprint — 3.45 lakh registered doctors, 8,593 dispensaries, 277 colleges, 34 research centres, and over 1,84,235 Ayushman Arogya Mandirs co-locating AYUSH at health centres — supplies hard figures on the scale of the traditional-medicine sector.
Example
The 1973-to-2020 transition is a clean worked example of converting an elected-council regulator into a nominated commission, the recurring template of recent regulatory reform in education and the professions.
Problematise
The backgrounder's own call to strengthen "scientific validation" and "evidence" flags the open challenge: integrating a system of medicine into mainstream healthcare while raising its evidence base and ethical standards.
Way-forward
Co-location at PHCs/CHCs, Centres of Excellence under AYURSWASTHYA, research grants under AYURGYAN's EMR component, and drug-quality control under AOGUSY together sketch a structured pathway for mainstreaming with quality safeguards.
Position
The government's stated stance is integration, not substitution — homoeopathy as a holistic, cost-effective, environmentally responsible complement aligned with UHC and SDG 3.
Deploys into: government policies and interventions in the health sector and their design (GS2.13); mainstreaming AYUSH and the regulation of medical education; traditional knowledge, medicinal plants and biodiversity.
Ministry of AYUSH (PIB Backgrounder) · 2026-04-09 · PRID 2250363 · PIB source ↗

Related: AYUSH systems hub · Schemes & Welfare · This week's cards